Hsa-miR-106b regulates the apoptosis and tumorigenesis of HCC via targeting Zbtb7a (Liang et al., 2018), while hsa-miR-195 inhibits metastasis of HCC via targeting FGF2 and VEGFA (Wang et al., 2015). The gene discussed is ZBTB7A; the disease is hepatocellular carcinoma.